Thyroid eye disease (TED), also called Graves’ orbitopathy, is an immune-mediated inflammatory disorder of the orbit that most often appears with Graves’ disease. Ayurveda should not be presented as a substitute for urgent ophthalmic or endocrine care, especially when vision is threatened. Its best role is adjunctive: protecting the ocular surface, calming Pitta-Kapha inflammation patterns, supporting sleep and stress regulation, and addressing the glandular Kapha-Meda terrain described in classical Galaganda-related practice.

In modern terms, TED involves activation of orbital fibroblasts, expansion of orbital fat and muscles, and accumulation of hydrophilic matrix within the orbit. This produces lid retraction, swelling, proptosis, gritty or dry eyes, diplopia, and in severe cases corneal damage or optic nerve compression. Ayurvedically, this presentation can be approached through two overlapping frames: Galaganda-type glandular pathology in the neck region and Netra disorders marked by Kapha congestion, Pitta heat, Vata dryness, and disturbed channels of nourishment.

When Ayurveda Is Appropriate in Thyroid Eye Disease

Ayurvedic care is appropriate only as supportive care alongside thyroid function management and ophthalmologic monitoring. Mild active or inactive TED may be supported with diet, stress reduction, ocular-surface protection, and carefully selected herbs. Moderate-to-severe active TED, rapidly progressive double vision, reduced vision, color desaturation, corneal ulceration, severe exposure, or optic nerve compression require prompt specialist-led treatment.

The practical aim is not to “decompress” the orbit with herbs. The aim is to reduce avoidable aggravating factors, support normal thyroid status, protect the cornea, improve sleep and digestion, and keep inflammation-provoking Pitta-Kapha habits under control while medical care handles disease activity and vision risk.

Understanding the Ayurvedic Pathogenesis

Galaganda is classically associated with swelling in the neck region and is described with Kapha, Vata, and Meda involvement. The Ayurvedic Pharmacopoeia of India lists Kanchanara as a stem-bark drug of Bauhinia variegata and identifies its actions with glandular enlargement patterns such as gandavriddhihara, while Kanchanara Guggulu is a recognized compound formula containing Kanchanara, Triphala, Trikatu, Varuna, aromatic spices, and purified Guggulu.

In TED, the visible eye features are better understood as a Netra-dominant expression of systemic imbalance rather than a separate classical disease label. Pitta is suggested by burning, redness, inflammation, irritability, heat intolerance, and active inflammatory signs. Kapha is suggested by puffiness, heaviness, orbital congestion, and tissue expansion. Vata becomes prominent when there is dryness, pain, lid lag, anxiety, insomnia, tremor, or unstable thyroid function. A rational protocol therefore needs cooling, decongesting, lubricating, and stabilizing measures rather than a single “thyroid herb.”

The Core Herbal Protocol

The following herbs and formulations are best used under a qualified Ayurvedic practitioner, with thyroid function tests and medication review. Doses vary by constitution, digestive strength, disease phase, pregnancy status, liver status, and concurrent medicines.

Key Ayurvedic Supports for Mild or Inactive Thyroid Eye Disease
Herb or Formula Botanical or Composition Ayurvedic Rationale Typical Use Pattern Safety Notes
Kanchanara Guggulu Kanchanara, Triphala, Trikatu, Varuna, Ela, Tvak, Patra, purified Guggulu Primary Kapha-Meda formula for glandular, cystic, and neck-node patterns such as granthi, gandamala, and apaci Often 2-3 g daily in divided doses when prescribed in classical API-style dosing Use with medical supervision if taking thyroid medicine, anticoagulants, antiplatelets, beta-blockers, or multiple prescriptions
Kanchanara Bauhinia variegata stem bark Astringent, light, dry, cooling, Kapha-Meda reducing support for glandular enlargement patterns Traditionally used as decoction material; API lists 20-30 g of drug for decoction Should be individualized; not a stand-alone treatment for Graves’ disease or TED
Triphala Haritaki, Bibhitaki, Amalaki Supports bowel regularity, antioxidant nourishment, and gentle nightly cleansing without aggressive depletion Commonly used at bedtime in churna or tablet form as directed May loosen stools; avoid homemade Triphala eye washes because non-sterile preparations can irritate or infect the eye
Haridra Curcuma longa rhizome Pitta-Kapha balancing kitchen and medicinal herb used for inflammatory tendencies Food-level turmeric or practitioner-selected extract Use caution with anticoagulants, gallbladder disease, high-dose extracts, or surgery planning
Shatavari Asparagus racemosus root Cooling, nourishing support when dryness, burning, fatigue, and tissue depletion dominate Powder, tablet, or ghrita-based use under guidance May be too heavy when Kapha congestion, sluggish digestion, or marked puffiness is dominant
Ashwagandha Withania somnifera root Reserved for selected patients with exhaustion, poor sleep, and stable non-hyperthyroid labs Only after thyroid labs confirm it is appropriate Avoid in active hyperthyroidism unless specifically cleared by the treating clinician; thyroid hormone changes and thyrotoxicosis have been reported

Critical safety note: In active Graves’ hyperthyroidism, do not self-prescribe Ashwagandha, Guggulu formulas, iodine, kelp, or “thyroid boosters.” Any herb used in TED should be disclosed to the endocrinologist and ophthalmologist so that thyroid labs, anticoagulant risk, liver tolerance, and drug interactions can be monitored.

Netra Tarpana for Ocular Surface Support

Netra Tarpana or Akshi Tarpana is a practitioner-performed ocular oleation therapy in which medicated ghee is retained around the eye for a defined period. In TED, its safest role is ocular-surface support for dryness, grittiness, and exposure tendency after an ophthalmologist has ruled out corneal ulcer, active infection, severe exposure keratopathy, or urgent sight-threatening disease.

For TED support, Triphala Ghrita or another suitable ghrita may be selected by the practitioner. Sessions should be gentle, short, and stopped immediately if there is pain, increased redness, discharge, blurred vision, or photophobia. Netra Tarpana should not be performed at home with unsterile ghee, powders, decoctions, or kitchen preparations.

  • Best indication: dry, irritated, fatigued eyes in stable mild or inactive disease.
  • Avoid during: active conjunctivitis, corneal ulcer, severe corneal exposure, acute eye pain, sudden vision change, or marked inflammatory flare.
  • Supportive pairing: preservative-free lubricating drops, nighttime ophthalmic ointment when prescribed, sunglasses outdoors, and head elevation during sleep.

Dietary Protocol for Pitta-Kapha Thyroid Eye Disease

The diet should be light enough to reduce Kapha congestion, cooling enough to calm Pitta, and nourishing enough not to worsen hyperthyroid weight loss, tremor, fatigue, or anxiety. Aggressive fasting, harsh detoxes, and excessive heating spices are inappropriate during active Graves’ symptoms.

Foods to emphasize:

  • Warm, freshly cooked meals that are easy to digest.
  • Bitter and astringent vegetables such as bitter gourd, leafy greens, methi leaves, bottle gourd, ridge gourd, and cooked greens suited to digestion.
  • Cooling digestive spices such as coriander, fennel, cumin, and small amounts of turmeric.
  • Amla, pomegranate, and other non-sour antioxidant fruits when tolerated.
  • Adequate protein from suitable vegetarian or non-vegetarian sources according to the patient’s diet and medical needs.

Foods and habits to minimize:

  • Kelp, dulse, seaweed tablets, iodine drops, and high-iodine supplements unless prescribed.
  • Excess sour, fermented, very spicy, deep-fried, and alcohol-containing foods during active heat, redness, or palpitations.
  • Heavy sweets, cold dairy desserts, frequent snacking, and late-night meals that increase Kapha and impair digestion.
  • Gluten only when there is diagnosed celiac disease, non-celiac gluten sensitivity, or a clear clinician-guided reason to restrict it.

External Therapies for Orbital Inflammation Patterns

External therapies should be selected for Vata-Pitta calming and stress regulation, not as mechanical treatments for proptosis. They are supportive measures and should be avoided during acute eye emergencies, fever, uncontrolled hyperthyroidism, severe hypertension, or unstable medical status.

Shirodhara: A steady stream of warm medicated liquid over the forehead can be used for calming Vata, improving sleep quality, and reducing stress reactivity. Brahmi oil, Ksheerabala oil, or other preparations may be chosen according to constitution and season.

Nasya: Nasya is classically used for disorders above the clavicle. In a TED-support plan, very gentle oil-based Nasya may be considered only after assessing nasal congestion, sinus infection, digestion, and eye status. It should not be forced, overdone, or used during acute infection, immediately after meals, or during a severe inflammatory flare.

Padabhyanga: Nightly foot massage with warm sesame oil, coconut oil, or a practitioner-selected oil is a simple Vata-pacifying practice for sleep, anxiety, and nervous-system steadiness. It is especially useful when palpitations, worry, insomnia, and eye discomfort worsen at night.

Kanchanara Guggulu as the Primary Formula

Kanchanara Guggulu is the central formula when the Ayurvedic picture is Kapha-Meda accumulation with glandular, nodular, or neck-region involvement. The Ayurvedic Pharmacopoeia of India lists Kanchanara Guggulu with Kanchanara bark, Triphala, Trikatu, Varuna, Ela, Tvak, Patra, and purified Guggulu, and gives a general dose of 2-3 g daily in divided doses.

For TED, this formula should be viewed as support for the Galaganda-related terrain, not as a proven replacement for antithyroid medication, steroids, biologic therapy, radiation, or surgery. It is most appropriate when digestion can tolerate it, Kapha-Meda signs are prominent, and the prescribing practitioner can coordinate with thyroid laboratory monitoring.

  • Usual supervised pattern: divided dosing after food with warm water or a suitable decoction.
  • Monitoring: TSH, free T4, free T3, symptoms, liver tolerance when relevant, eye activity score, and medication changes.
  • Caution: Guggulu-containing formulas require extra care in people taking anticoagulants, antiplatelets, thyroid medication, beta-blockers, hormonal therapies, or multiple prescription medicines.

Monitoring and Integration with Conventional Care

TED activity is commonly assessed with the Clinical Activity Score, while severity may be described with systems such as NOSPECS or EUGOGO severity categories. A CAS of 3 or more out of 7 usually indicates active disease and should trigger close ophthalmologic follow-up.

The Ayurvedic plan described here is not a replacement for any of the following when indicated:

  • Preservative-free lubricants, ointments, taping, prisms, or other ocular-surface measures.
  • Control of thyroid dysfunction with antithyroid drugs, radioiodine when appropriate, surgery, beta-blockers, or thyroid hormone replacement after definitive therapy.
  • Intravenous glucocorticoids or other immunomodulatory treatment for active moderate-to-severe disease.
  • IGF-1 receptor inhibitor therapy where appropriate and available.
  • Orbital radiotherapy or decompression surgery when sight or function is threatened.

Selenium may be considered for mild active TED when approved by the treating clinician, commonly as selenium selenite 100 mcg twice daily for six months in appropriate patients. It should not be combined with multiple selenium-containing supplements or used beyond need, because excess selenium can be harmful.

Yoga and Pranayama for Thyroid-Eye Support

Yoga support should be calming, non-heating, and non-inverting. The goal is to reduce stress load, improve breath regulation, and stabilize Vata without increasing orbital venous pressure or eye strain.

  • Sitali or Sitkari pranayama: gentle cooling breath for Pitta-dominant heat, irritability, and burning sensations; avoid breath retention.
  • Bhramari pranayama: soft humming exhalation for anxiety, sleep preparation, and parasympathetic settling.
  • Trataka: avoid during active dryness, corneal exposure, pain, or inflammatory TED; if used later, it must be brief, gentle, and stopped before strain.
  • Avoid inversions: headstand, shoulderstand, long downward-facing holds, and forceful breath practices are not suitable when eye pressure, orbital congestion, palpitations, or active eye inflammation is present.

Practical Starting Point

For a patient with mild TED already under ophthalmology and endocrinology care, the safest first step is simple: maintain normal thyroid function, stop smoking if applicable, use prescribed eye lubrication, avoid high-iodine supplements, ask the physician whether selenium is suitable, eat a light Pitta-Kapha balancing diet, and add only practitioner-supervised Ayurvedic herbs. External eye therapies should be performed only in a clinical setting after corneal safety has been confirmed.

Disclaimer: This article is educational and does not replace care from qualified ophthalmologists, endocrinologists, physicians, or Ayurvedic practitioners. Thyroid eye disease can threaten vision and requires professional monitoring. Do not stop or change prescribed treatment based on this article.

References

  1. NCBI
  2. Nature (nature.com)
  3. A review of TSHR- and IGF-1R-related pathogenesis and treatment of Graves’ orbitopathy (2023), PubMed Central
  4. The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy (2021), PubMed
  5. Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association (2022), PubMed Central
  6. Nejm (nejm.org)
  7. NIDDK
  8. Academic (academic.oup.com)
  9. Celiac Disease and Autoimmune Thyroid Disease: The Two Peas in a Pod (2022), PubMed Central
  10. Ayurvedic Pharmacopoeia of India
  11. Natural Ingredient Resource Center
  12. Therapeutic Uses of Triphala in Ayurvedic Medicine (2017), PubMed Central
  13. Efficacy of Triphala Ghrita and Goghrita Manda Tarpana in the management of Shushkakshipaka w.s.r. to dry eye syndrome: An open labelled randomized comparative clinical trial (2020), PubMed Central
  14. Impact of Shirodhara on biological markers of stress: A case study (2021), PubMed Central
  15. Shirodhara: A psycho-physiological profile in healthy volunteers (2013), PubMed Central
  16. Ayushdhara (ayushdhara.in)
  17. Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients: A Double-Blind, Randomized Placebo-Controlled Trial (2018), PubMed
  18. Ashwagandha as a Unique Cause of Thyrotoxicosis Presenting With Supraventricular Tachycardia (2022), PubMed Central
  19. Antioxidant and anti-inflammatory effects of curcumin/turmeric supplementation in adults: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials (2023), PubMed
  20. Plant profile, phytochemistry and pharmacology of Asparagus racemosus (Shatavari): A review (2013), PubMed Central
  21. Anti-inflammatory activity of a novel flavonol glycoside from the Bauhinia variegata Linn (2003), PubMed
  22. What is the impact of stress on the onset and anti-thyroid drug therapy in patients with graves’ disease: a systematic review and meta-analysis (2023), PubMed Central
  23. Effect of Bhramari Pranayama intervention on stress, anxiety, depression and sleep quality among COVID 19 patients in home isolation (2022), PubMed Central
  24. A clinical study to evaluate the efficacy of Trataka Yoga Kriya and eye exercises (non-pharmocological methods) in the management of Timira (Ammetropia and Presbyopia) (2012), PubMed Central
  25. Journals (journals.plos.org)
Tags: autoimmune Eye Health Galaganda Graves Disease Netra Tarpana Thyroid Eye Disease